BGM Group Ltd.(BGM)Earnings, Financials & Key Ratios
BGM•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryTraditional Chinese medicine producers
AboutBGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.Show more
- Revenue$25M-46.0%
- EBITDA$673K+145.9%
- Net Income-$1M+81.5%
- EPS (Diluted)-0.20+81.5%
- Gross Margin16.39%+335.0%
- EBITDA Margin2.68%+185.0%
- Operating Margin-2.25%+60.0%
- Net Margin-5.75%+65.7%
- ROE-3.26%+79.2%
BGM Key Insights
BGM Group Ltd. (BGM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 7 (bottom 7%)
- ✗Sales declining 11.4% over 5 years
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when BGM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BGM Price & Volume
BGM Group Ltd. (BGM) stock price & volume — 10-year historical chart
Loading chart...
BGM Growth Metrics
BGM Group Ltd. (BGM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-11.45%
3 Years-23.97%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years11.47%
5 Years4.16%
3 Years-0.92%
Last Year-1.27%
BGM Peer Comparison
BGM Group Ltd. (BGM) competitors in Traditional Chinese medicine producers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GORO | 182.75M | 1.33 | -28.30 | 44.01% | 5.15% | 19.13% | 0.00 | |
 USAS | 1.43B | 5.36 | -16.24 | 17.71% | -36.33% | -41.36% | 0.21 | |
 HL | 10.7B | 15.96 | 32.57 | 53.03% | 35.55% | 22.55% | 0.12 | |
 CDE | 11.4B | 17.51 | 19.46 | 96.41% | 31.15% | 15.17% | 0.11 | |
 EXK | 2.55B | 8.61 | -20.02 | 115.25% | -3.48% | -3.75% | 0.42 | |
 PAAS | 20.65B | 49.00 | 18.77 | 30.63% | 31.69% | 19.63% | 0.13 | |
 AG | 8.89B | 18.00 | 51.43 | 128.18% | 19.72% | 9.49% | 0.10 | |
 NEM | 115B | 103.79 | 16.19 | 19.08% | 30.54% | 15.58% | 0.01 |
Compare BGM vs Peers
BGM Group Ltd. (BGM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BGM Income Statement
BGM Group Ltd. (BGM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 22.54M | 50.37M | 46.1M | 50.03M | 57.1M | 64.86M | 46.47M | 25.1M |
Revenue Growth % | - | 123.49% | -8.48% | 8.54% | 14.12% | 13.58% | -28.35% | -45.99% |
Cost of Goods Sold | 19.16M | 42.24M | 36.42M | 42.49M | 51.46M | 58.63M | 44.72M | 20.98M |
COGS % of Revenue | 84.99% | 83.85% | 79% | 84.93% | 90.13% | 90.4% | 96.23% | 83.61% |
Gross Profit | 3.38M▲ 0% | 8.13M▲ 140.4% | 9.68M▲ 19.0% | 7.54M▼ 22.1% | 5.64M▼ 25.2% | 6.23M▲ 10.4% | 1.75M▼ 71.9% | 4.11M▲ 134.9% |
Gross Margin % | 15.01% | 16.15% | 21% | 15.07% | 9.87% | 9.6% | 3.77% | 16.39% |
Gross Profit Growth % | - | 140.44% | 19.03% | -22.12% | -25.21% | 10.44% | -71.87% | 134.93% |
Operating Expenses | 2.25M | 2.16M | 3.5M | 2.73M | 3.25M | 4.13M | 4.36M | 4.68M |
OpEx % of Revenue | 9.99% | 4.29% | 7.6% | 5.45% | 5.69% | 6.36% | 9.39% | 18.64% |
Selling, General & Admin | 2.25M | 2.16M | 3.5M | 2.73M | 3.25M | 2.9M | 3.79M | 3.32M |
SG&A % of Revenue | 9.99% | 4.29% | 7.6% | 5.45% | 5.69% | 4.47% | 8.16% | 13.22% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 1.22M | 568.47K | 1.36M |
R&D % of Revenue | - | - | - | - | - | 1.89% | 1.22% | 5.42% |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 1.13M▲ 0% | 5.97M▲ 428.2% | 6.18M▲ 3.5% | 4.81M▼ 22.1% | 2.39M▼ 50.4% | 2.1M▼ 12.0% | -2.61M▼ 224.2% | -563.77K▲ 78.4% |
Operating Margin % | 5.02% | 11.86% | 13.4% | 9.62% | 4.18% | 3.24% | -5.62% | -2.25% |
Operating Income Growth % | - | 428.2% | 3.47% | -22.13% | -50.36% | -11.98% | -224.17% | 78.4% |
EBITDA | 2.37M | 7.23M | 7.37M | 5.98M | 3.59M | 3.33M | -1.47M | 673.46K |
EBITDA Margin % | 10.53% | 14.35% | 15.98% | 11.95% | 6.29% | 5.13% | -3.16% | 2.68% |
EBITDA Growth % | - | 204.55% | 1.95% | -18.84% | -39.97% | -7.32% | -144.1% | 145.91% |
D&A (Non-Cash Add-back) | 1.24M | 1.25M | 1.19M | 1.17M | 1.2M | 1.22M | 1.14M | 1.24M |
EBIT | 2.14M | 6.36M | 7.17M | 6.05M | 2.95M | 2.52M | -2.42M | -357.36K |
Net Interest Income | -282.84K | -216.19K | -223.66K | -242.88K | -57.67K | 24.86K | 99.19K | -639.51K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 24.86K | 99.19K | 0 |
Interest Expense | 282.84K | 216.19K | 223.66K | 242.88K | 57.67K | 0 | 0 | 639.51K |
Other Income/Expense | 728.92K | 174.6K | 763.38K | 994.21K | 975.23K | -541.44K | -5.29M | -1.57M |
Pretax Income | 1.86M▲ 0% | 6.15M▲ 230.5% | 6.94M▲ 13.0% | 5.81M▼ 16.4% | 3.36M▼ 42.1% | 1.56M▼ 53.6% | -7.9M▼ 606.4% | -2.14M▲ 73.0% |
Pretax Margin % | 8.25% | 12.2% | 15.06% | 11.6% | 5.89% | 2.41% | -17.01% | -8.52% |
Income Tax | 321.46K | 943.36K | 1.03M | 864.91K | 255.13K | 194.3K | 219.17K | -619.98K |
Effective Tax Rate % | 17.29% | 15.35% | 14.89% | 14.9% | 7.59% | 12.45% | -2.77% | 29.01% |
Net Income | 1.41M▲ 0% | 5.17M▲ 265.4% | 5.33M▲ 3.1% | 5.06M▼ 5.0% | 3.15M▼ 37.7% | 1.08M▼ 65.9% | -7.78M▼ 822.6% | -1.44M▲ 81.5% |
Net Margin % | 6.28% | 10.26% | 11.57% | 10.12% | 5.52% | 1.66% | -16.74% | -5.75% |
Net Income Growth % | - | 265.4% | 3.15% | -5.04% | -37.74% | -65.85% | -822.64% | 81.46% |
Net Income (Continuing) | 1.54M | 5.2M | 5.91M | 4.94M | 3.11M | 1.37M | -8.12M | -1.52M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 2.41M | 2.4M | 2.74M | 2.74M | 1.81M | 1.91M | 1.56M | 1.35M |
EPS (Diluted) | 0.20▲ 0% | 0.74▲ 270.0% | 0.76▲ 2.7% | 0.72▼ 5.3% | 0.45▼ 37.5% | 0.15▼ 66.7% | -1.08▼ 820.0% | -0.20▲ 81.5% |
EPS Growth % | - | 270% | 2.7% | -5.26% | -37.5% | -66.67% | -820% | 81.48% |
EPS (Basic) | 0.20 | 0.74 | 0.76 | 0.72 | 0.45 | 0.15 | -1.08 | -0.20 |
Diluted Shares Outstanding | 7M | 7M | 7M | 7M | 6.82M | 7.23M | 7.23M | 7.23M |
Basic Shares Outstanding | 7M | 7M | 7M | 7M | 6.82M | 7.23M | 7.23M | 7.23M |
Dividend Payout Ratio | - | 14.2% | - | - | - | - | - | - |
BGM Balance Sheet
BGM Group Ltd. (BGM) balance sheet — assets, liabilities & shareholders' equity
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 21.96M | 22.17M | 24.97M | 37.52M | 40.37M | 30.03M | 34.51M | 29.77M |
Cash & Short-Term Investments | 5.37M | 5.28M | 4.59M | 11.87M | 10.47M | 14.32M | 22.42M | 18.14M |
Cash Only | 5.37M | 5.26M | 4.59M | 11.87M | 10.47M | 14.32M | 7.48M | 9.82M |
Short-Term Investments | 0 | 14.58K | 0 | 0 | 0 | 0 | 14.94M | 8.32M |
Accounts Receivable | 1.01M | 5.29M | 6.14M | 12.62M | 13.47M | 4.87M | 6.35M | 5.77M |
Days Sales Outstanding | 16.33 | 38.36 | 48.62 | 92.1 | 86.1 | 27.42 | 49.91 | 83.98 |
Inventory | 12.85M | 9.59M | 12.52M | 11.99M | 12.5M | 8.88M | 4.99M | 5.05M |
Days Inventory Outstanding | 244.95 | 82.84 | 125.52 | 103.03 | 88.63 | 55.28 | 40.74 | 87.84 |
Other Current Assets | 944K | 363.99K | 351.92K | 384.85K | 2.14M | 659.78K | 0 | 0 |
Total Non-Current Assets | 11.43M | 11.17M | 10.3M | 10.63M | 34.99M | 34.49M | 16.75M | 23.23M |
Property, Plant & Equipment | 8.84M | 8.49M | 7.67M | 7.66M | 11.48M | 12.29M | 12.71M | 14.91M |
Fixed Asset Turnover | 2.55x | 5.93x | 6.01x | 6.53x | 4.97x | 5.28x | 3.66x | 1.68x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 2.07M | 1.96M | 1.83M | 1.88M | 1.93M | 1.73M | 3.42M | 4.54M |
Long-Term Investments | 163.03K | 407.35K | 539.68K | 540.52K | 20.96M | 20.09M | 606K | 3.36M |
Other Non-Current Assets | 0 | 0 | 0 | 179.32K | 188.91K | 172.91K | 0 | 0 |
Total Assets | 33.38M▲ 0% | 33.34M▼ 0.1% | 35.27M▲ 5.8% | 48.14M▲ 36.5% | 75.35M▲ 56.5% | 64.53M▼ 14.4% | 51.26M▼ 20.6% | 53M▲ 3.4% |
Asset Turnover | 0.68x | 1.51x | 1.31x | 1.04x | 0.76x | 1.01x | 0.91x | 0.47x |
Asset Growth % | - | -0.13% | 5.79% | 36.51% | 56.52% | -14.37% | -20.56% | 3.41% |
Total Current Liabilities | 17.97M | 14.29M | 11.66M | 18.42M | 18.17M | 9.18M | 6.66M | 8.78M |
Accounts Payable | 4.69M | 3.76M | 3.57M | 4.38M | 6.64M | 5.29M | 3.59M | 4.13M |
Days Payables Outstanding | 89.29 | 32.47 | 35.78 | 37.6 | 47.12 | 32.93 | 29.32 | 71.76 |
Short-Term Debt | 6.94M | 4.22M | 4.9M | 7.35M | 7.87M | 1.67M | 479.71K | 0 |
Deferred Revenue (Current) | 5.05M | 4.63M | 2.31M | 3.93M | 2.84M | 677.96K | 1.11M | 568.5K |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio | 1.22x | 1.55x | 2.14x | 2.04x | 2.22x | 3.27x | 5.18x | 3.39x |
Quick Ratio | 0.51x | 0.88x | 1.07x | 1.39x | 1.53x | 2.30x | 4.43x | 2.82x |
Cash Conversion Cycle | 171.99 | 88.73 | 138.35 | 157.52 | 127.61 | 49.77 | 61.33 | 100.06 |
Total Non-Current Liabilities | 1.76M | 1.33M | 972.34K | 877.86K | 509.93K | 382.48K | 246.45K | 134.39K |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 155.72K | 106.18K | 72.54K | 24.57K | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 19.73M | 15.62M | 12.63M | 19.3M | 18.68M | 9.56M | 6.91M | 8.91M |
Total Debt | 6.94M | 4.22M | 4.9M | 7.59M | 8.03M | 1.77M | 577.85K | 0 |
Net Debt | 1.58M | -1.04M | 308.69K | -4.28M | -2.44M | -12.55M | -6.9M | -9.82M |
Debt / Equity | 0.51x | 0.24x | 0.22x | 0.26x | 0.14x | 0.03x | 0.01x | - |
Debt / EBITDA | 2.93x | 0.58x | 0.67x | 1.27x | 2.24x | 0.53x | - | - |
Net Debt / EBITDA | 0.66x | -0.14x | 0.04x | -0.72x | -0.68x | -3.77x | - | -14.58x |
Interest Coverage | 4.00x | 27.62x | 27.63x | 19.81x | 41.41x | - | - | -0.88x |
Total Equity | 13.66M▲ 0% | 17.72M▲ 29.8% | 22.64M▲ 27.7% | 28.84M▲ 27.4% | 56.67M▲ 96.5% | 54.96M▼ 3.0% | 44.35M▼ 19.3% | 44.09M▼ 0.6% |
Equity Growth % | - | 29.76% | 27.74% | 27.4% | 96.48% | -3.01% | -19.31% | -0.58% |
Book Value per Share | 1.95 | 2.53 | 3.23 | 4.12 | 8.31 | 7.61 | 6.14 | 6.10 |
Total Shareholders' Equity | 11.24M | 15.32M | 19.89M | 26.1M | 54.86M | 53.05M | 42.79M | 42.74M |
Common Stock | 50K | 50K | 50K | 50K | 59.58K | 59.58K | 59.58K | 59.58K |
Retained Earnings | 3.06M | 2.87M | 7.56M | 12.2M | 14.69M | 15.51M | 5.9M | 4.35M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 440.33K | 150.36K | 30.64K | 1.6M | 3.71M | 1.07M | 425.25K | 1.92M |
Minority Interest | 2.41M | 2.4M | 2.74M | 2.74M | 1.81M | 1.91M | 1.56M | 1.35M |
BGM Cash Flow Statement
BGM Group Ltd. (BGM) cash flow — operating, investing & free cash flow history
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 2.68M | 4.44M | -580.2K | 5.08M | 345.03K | 12.65M | 312.21K | 544.24K |
Operating CF Margin % | 11.9% | 8.81% | -1.26% | 10.15% | 0.6% | 19.51% | 0.67% | 2.17% |
Operating CF Growth % | - | 65.49% | -113.07% | 974.88% | -93.2% | 3567.52% | -97.53% | 74.32% |
Net Income | 1.54M | 5.2M | 5.91M | 4.94M | 3.11M | 1.37M | -8.12M | -1.52M |
Depreciation & Amortization | 1.24M | 1.25M | 1.19M | 1.17M | 1.2M | 1.22M | 1.14M | 1.24M |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 20K | 0 | 0 |
Deferred Taxes | 57.51K | 15.8K | 48.66K | -86.5K | -46.19K | 189.84K | 203.54K | -406.85K |
Other Non-Cash Items | 71.87K | 205.47K | -30.78K | -160.86K | -246.34K | 1.1M | 5.98M | 445.31K |
Working Capital Changes | -227.6K | -2.24M | -7.69M | -785.07K | -3.67M | 8.75M | 1.11M | 785.7K |
Change in Receivables | 1.86M | -4.06M | -1.46M | -6.24M | -157.5K | 9.77M | -2.89M | 1.33M |
Change in Inventory | -7.26M | 2.81M | -3.49M | 1.4M | 46.8K | 2.23M | 3.4M | 958.65K |
Change in Payables | 2.72M | -824.54K | -50.04K | 613.34K | 2.02M | -805.44K | -1.62M | 378.98K |
Cash from Investing | -1.69M | -1.39M | -800.18K | -375.59K | -24.2M | -3.26M | -4.74M | 983.42K |
Capital Expenditures | -1.52M | -1.12M | -616.39K | -449.77K | -3.49M | -3.23M | -1.85M | -2.85M |
CapEx % of Revenue | 6.75% | 2.22% | 1.34% | 0.9% | 6.11% | 4.98% | 3.98% | 11.37% |
Acquisitions | 0 | 0 | -133.55K | 0 | -706.66K | 0 | -28.36K | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -7.13K | 0 | -635 | -8.8K | -1.81K | -26.68K | -1.87M | -1.02M |
Cash from Financing | 1.25M | -3.12M | 507.2K | 2.14M | 23.99M | -5.94M | -2.92M | -491.73K |
Debt Issued (Net) | 1.75M | -2.63M | 872.51K | 2.14M | 123.7K | -5.94M | -1.19M | -491.73K |
Equity Issued (Net) | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 |
Dividends Paid | 0 | -733.94K | 0 | 0 | 0 | 0 | -1.79M | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -493.14K | 247.7K | -365.31K | 0 | 0 | 0 | 56.71K | 0 |
Net Change in Cash | 2.31M▲ 0% | -246.08K▼ 110.7% | -1.03M▼ 318.7% | 7.27M▲ 805.9% | 740.24K▼ 89.8% | 2.37M▲ 220.4% | -7.5M▼ 416.4% | 2.34M▲ 131.2% |
Free Cash Flow | 1.15M▲ 0% | 3.32M▲ 188.2% | -1.2M▼ 136.1% | 0▲ 100.0% | -3.15M▲ 0% | 9.4M▲ 398.4% | -3.4M▼ 136.2% | -3.39M▲ 0.4% |
FCF Margin % | 5.11% | 6.59% | -2.6% | - | -5.51% | 14.49% | -7.32% | -13.5% |
FCF Growth % | - | 188.15% | -136.05% | 100% | - | 398.42% | -136.21% | 0.43% |
FCF per Share | 0.16 | 0.47 | -0.17 | - | -0.46 | 1.30 | -0.47 | -0.47 |
FCF Conversion (FCF/Net Income) | 1.90x | 0.86x | -0.11x | 1.00x | 0.11x | 11.75x | -0.04x | -0.38x |
Interest Paid | 281.7K | 223.77K | 210.59K | 280.17K | 152.5K | 122.24K | 3.66K | 4.26K |
Taxes Paid | 48K | 658.41K | 1.11M | 275.61K | 820.97K | 0 | 27.44K | 21.91K |
BGM Key Ratios
BGM Group Ltd. (BGM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 10.36% | 32.95% | 26.42% | 19.67% | 7.37% | 1.93% | -15.67% | -3.26% |
Return on Invested Capital (ROIC) | 5.57% | 28.06% | 23.39% | 15.19% | 4.55% | 3.26% | -4.9% | -1.18% |
Gross Margin | 15.01% | 16.15% | 21% | 15.07% | 9.87% | 9.6% | 3.77% | 16.39% |
Net Margin | 6.28% | 10.26% | 11.57% | 10.12% | 5.52% | 1.66% | -16.74% | -5.75% |
Debt / Equity | 0.51x | 0.24x | 0.22x | 0.26x | 0.14x | 0.03x | 0.01x | - |
Interest Coverage | 4.00x | 27.62x | 27.63x | 19.81x | 41.41x | - | - | -0.88x |
FCF Conversion | 1.90x | 0.86x | -0.11x | 1.00x | 0.11x | 11.75x | -0.04x | -0.38x |
Revenue Growth | - | 123.49% | -8.48% | 8.54% | 14.12% | 13.58% | -28.35% | -45.99% |
Related:BGM Dividend History·BGM Revenue History·BGM Price History·BGM P/E History·BGM Financial Ratios·BGM Institutional Holders
BGM Frequently Asked Questions
BGM Group Ltd. (BGM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
BGM Group Ltd. (BGM) reported $25.1M in revenue for fiscal year 2024. This represents a 11% increase from $22.5M in 2017.
BGM Group Ltd. (BGM) saw revenue decline by 46.0% over the past year.
BGM Group Ltd. (BGM) reported a net loss of $1.4M for fiscal year 2024.
Dividend & Returns
BGM Group Ltd. (BGM) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.
BGM Group Ltd. (BGM) had negative free cash flow of $3.4M in fiscal year 2024, likely due to heavy capital investments.